Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy

Background: Despite the high mortality of cardiovascular disease (CVD) in diabetic patients with renal injury, few studies have compared cardiovascular characteristics and outcomes between patients with diabetic nephropathy (DN) and non-diabetic renal disease (NDRD). Methods: A total of 326 type 2 d...

Full description

Bibliographic Details
Main Authors: Yiyun Wang, Ting Zhou, Qiming Zhang, Yang Fei, Ze Li, Shiqi Li, Li He, Qunzi Zhang, Yang Dong, Ying Fan, Niansong Wang
Format: Article
Language:English
Published: Karger Publishers 2020-03-01
Series:Kidney & Blood Pressure Research
Subjects:
Online Access:https://www.karger.com/Article/FullText/505919
_version_ 1818452819413303296
author Yiyun Wang
Ting Zhou
Qiming Zhang
Yang Fei
Ze Li
Shiqi Li
Li He
Qunzi Zhang
Yang Dong
Ying Fan
Niansong Wang
author_facet Yiyun Wang
Ting Zhou
Qiming Zhang
Yang Fei
Ze Li
Shiqi Li
Li He
Qunzi Zhang
Yang Dong
Ying Fan
Niansong Wang
author_sort Yiyun Wang
collection DOAJ
description Background: Despite the high mortality of cardiovascular disease (CVD) in diabetic patients with renal injury, few studies have compared cardiovascular characteristics and outcomes between patients with diabetic nephropathy (DN) and non-diabetic renal disease (NDRD). Methods: A total of 326 type 2 diabetes mellitus patients with renal biopsy were assigned to DN and NDRD groups. Echocardiography and Doppler ultrasound were performed to evaluate left ventricular hypertrophy (LVH) and peripheral atherosclerosis disease (PAD). Renal and cardiovascular survival rates were compared between the DN and NDRD groups by Kaplan-Meier analysis. Risk factors for renal and cardiovascular events in DN patients were identified by a Cox proportional hazards model. Results: In total, 179 patients entered the DN group (54.9%) and 147 made up the NDRD group (45.1%). The presence of diabetic retinopathy, family history of diabetes, and dependence on insulin therapy were associated with the presence of DN. DN patients had more CVD with more severe LVH and PAD. Poorer renal (log-rank χ2 = 26.534, p < 0.001) and cardiovascular (log-rank χ2 = 16.257, p < 0.001) prognoses were seen in the DN group. DR (HR 1.539, 95% CI 1.332–1.842), eGFR (HR 0.943, 95% CI 0.919–0.961), and 24-h proteinuria (HR 1.211, 95% CI 1.132–1.387) were identified as risk factors for renal endpoints. Age (HR 1.672, 95% CI 1.487–1.821), HbA1C (HR 1.398, 95% CI 1.197–1.876), and 24-h proteinuria (HR 1.453, 95% CI 1.289–1.672) were associated with cardiovascular endpoints. Conclusion: Patients with DN had more severe CVD along with poorer renal and cardiovascular prognoses than those with NDRD.
first_indexed 2024-12-14T21:29:09Z
format Article
id doaj.art-336bf5e9fabe4de2ad0af9f0014c7b2f
institution Directory Open Access Journal
issn 1420-4096
1423-0143
language English
last_indexed 2024-12-14T21:29:09Z
publishDate 2020-03-01
publisher Karger Publishers
record_format Article
series Kidney & Blood Pressure Research
spelling doaj.art-336bf5e9fabe4de2ad0af9f0014c7b2f2022-12-21T22:46:43ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432020-03-0111310.1159/000505919505919Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic NephropathyYiyun WangTing ZhouQiming ZhangYang FeiZe LiShiqi LiLi HeQunzi ZhangYang DongYing FanNiansong WangBackground: Despite the high mortality of cardiovascular disease (CVD) in diabetic patients with renal injury, few studies have compared cardiovascular characteristics and outcomes between patients with diabetic nephropathy (DN) and non-diabetic renal disease (NDRD). Methods: A total of 326 type 2 diabetes mellitus patients with renal biopsy were assigned to DN and NDRD groups. Echocardiography and Doppler ultrasound were performed to evaluate left ventricular hypertrophy (LVH) and peripheral atherosclerosis disease (PAD). Renal and cardiovascular survival rates were compared between the DN and NDRD groups by Kaplan-Meier analysis. Risk factors for renal and cardiovascular events in DN patients were identified by a Cox proportional hazards model. Results: In total, 179 patients entered the DN group (54.9%) and 147 made up the NDRD group (45.1%). The presence of diabetic retinopathy, family history of diabetes, and dependence on insulin therapy were associated with the presence of DN. DN patients had more CVD with more severe LVH and PAD. Poorer renal (log-rank χ2 = 26.534, p < 0.001) and cardiovascular (log-rank χ2 = 16.257, p < 0.001) prognoses were seen in the DN group. DR (HR 1.539, 95% CI 1.332–1.842), eGFR (HR 0.943, 95% CI 0.919–0.961), and 24-h proteinuria (HR 1.211, 95% CI 1.132–1.387) were identified as risk factors for renal endpoints. Age (HR 1.672, 95% CI 1.487–1.821), HbA1C (HR 1.398, 95% CI 1.197–1.876), and 24-h proteinuria (HR 1.453, 95% CI 1.289–1.672) were associated with cardiovascular endpoints. Conclusion: Patients with DN had more severe CVD along with poorer renal and cardiovascular prognoses than those with NDRD.https://www.karger.com/Article/FullText/505919renal biopsydiabetic nephropathynon-diabetic renal diseaserenal prognosiscardiovascular prognosis
spellingShingle Yiyun Wang
Ting Zhou
Qiming Zhang
Yang Fei
Ze Li
Shiqi Li
Li He
Qunzi Zhang
Yang Dong
Ying Fan
Niansong Wang
Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
Kidney & Blood Pressure Research
renal biopsy
diabetic nephropathy
non-diabetic renal disease
renal prognosis
cardiovascular prognosis
title Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
title_full Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
title_fullStr Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
title_full_unstemmed Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
title_short Poor Renal and Cardiovascular Outcomes in Patients with Biopsy-Proven Diabetic Nephropathy
title_sort poor renal and cardiovascular outcomes in patients with biopsy proven diabetic nephropathy
topic renal biopsy
diabetic nephropathy
non-diabetic renal disease
renal prognosis
cardiovascular prognosis
url https://www.karger.com/Article/FullText/505919
work_keys_str_mv AT yiyunwang poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT tingzhou poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT qimingzhang poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT yangfei poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT zeli poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT shiqili poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT lihe poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT qunzizhang poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT yangdong poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT yingfan poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy
AT niansongwang poorrenalandcardiovascularoutcomesinpatientswithbiopsyprovendiabeticnephropathy